Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T22:42:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T14:19:25.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T00:17:56.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:40.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; there is no visible impact on study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:23:50.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, a minor UI/version update with no changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:10:47.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.